----- Original Message -----
From: dredmond at efn.org
The pharma issue is especially interesting, because most the
semi-periphery is just beginning to invest heavily in its healthcare
networks -- China is upgrading its system, Russia is trying to do the
same, etc. This will be a powerful counterweight to the corporate monsters
of Big Pharma.
-- DRR
___________________________________
http://mailman.lbo-talk.org/mailman/listinfo/lbo-talk